Effect of chromium on diabetes mellitus type2 treatment
Phase 2
- Conditions
- Diabetes.Diabetes mellitusE10, E11,
- Registration Number
- IRCT2013012812311N1
- Lead Sponsor
- Private
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. HbA1c=10%, HbA1c=7%; 2. DM2; 3. BMI=35, BMI=25; 4. Stability of antidiabetic treatment during recent 3 mounths; 5. Age 30-65 years. Exclusion criteria: 1. Cr?1.5 (men), Cr>1.4 (female); 2. Liver function test (ALT, AST) >2 fold of upper limit normal; 3. Pregnancy; 4. Heart Failure; 5. Chronic Liver disease; 6. Uncontrolled hypertension; 7. Immunosupression disease and immunosupresive therapy; 8. Alcohol use and other drug abuse; 9. Psychological unhealthy; 10. Confined to bed during recent 1 years.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ric acid. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.;HbA1c. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.;HDL- C. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.;LDL- C. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.;TG. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.;FPG. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.;BS 2hpp. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.;BMI. Timepoint: Before intervension & 3 months later. Method of measurement: kg/m2.;Creatinine. Timepoint: Before intervension & 3 months later. Method of measurement: mg/dl- labratory kit.
- Secondary Outcome Measures
Name Time Method